Monitoring in vivo transcription with synthetic serum markers
Watanabe, S.; Lee, S.; Harb, M.; Nouraein, S.; Raisley, E.; Li, H.; Buitrago, N. S.; Pforr, B.; Szablowski, J. O.
Show abstract
Understanding transcription profiles of living tissues is critical for biology and medicine. However, measurement of the transcript levels is typically done in homogenized tissues post-mortem. Here, we present a new platform that enables non-invasive monitoring of specific mRNA levels in vivo, without tissue destruction. We achieved this by combining two cutting-edge tools - synthetic serum markers, called Released Markers of Activity (RMAs), and RNA-based sensors of transcription. We call this platform IN-vivo Tracking of ACtive Transcription, or INTACT. In INTACT, when the target mRNA is expressed, the RNA sensor detects it and triggers the production and release of RMA reporters into the blood. Once in blood, the RMAs can be easily measured through a simple blood draw. Our data shows that INTACT can measure transcription of transgenes, as well as endogenous transcripts, such as c-Fos or Arc, both in vivo in the brain and in tissue culture. INTACT enables simple measurement of transcript level histories in genetically-targetable cell populations of living animals.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Parallel Labeled-Line Organization of Sympathetic Outflow for Selective Organ Regulation in Mice 97%
- Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins 97%
- A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS/FTD 97%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.